Abstract Interleukin-33 (IL-33) but not soluble ST2 (sST2) exerts anti-inflammatory and
protective effects in several tissues. Aldosterone, a proinflammatory mediator which …

Abstract Suppression of tumorigenicity 2 (ST2) mediates the effect of Interleukin-33 (IL-33).
Few data are reported on the relationship between IL-33/ST2 and obesity. We aimed to …

Rationale: Chronic low-grade inflammation involving adipose tissue likely contributes to the
metabolic consequences of obesity. The cytokine interleukin (IL)-33 and its receptor ST2 are …

Objective: Obesity is associated with chronic inflammation of the adipose tissue, which
contributes to obesity-associated complications such as insulin resistance and type 2 …

Background The function of the Interleukin-33 (IL-33)/ST2 system has been mainly
investigated on immunological aspects, but recent data suggest that this pathway plays also …

Obesity is associated with insulin resistance and inflammation thought to be caused by a
visceral adipose tissue (VAT)–localized reduction in immunoregulatory cells and increase in …

As a cytokine in interleukin-1 (IL-1) family, interleukin-33 (IL-33) usually exists in the
cytoplasm and cell nucleus. When the cells are activated or damaged, IL-33 can be secreted …

IL-33 is a cytokine that belongs to the IL-1 family and is classically associated with type 2-
like immune responses. In the adipose tissue, IL-33 is related to the beiging of adipocytes …

Group 2 innate lymphoid cells (ILC2s) in white adipose tissue (WAT) promotes WAT
browning and assists in preventing the development of obesity. However, how ILC2 in …

Obesity is a syndrome that attributes to many factors such as genetics, diet, lifestyle and
environment, which includes an imbalance of immune regulation. IL-33, as a new member of …